Skip to main content
Standard Chemical & Pharmaceutical Co., Ltd. logo

Standard Chemical & Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 1720 ISIN · TW0001720001 TW Manufacturing
Open in API
Filings indexed 1,594 across all filing types
Latest filing 2026-05-14 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 1720

About Standard Chemical & Pharmaceutical Co., Ltd.

http://www.standard.com.tw

Standard Chemical & Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical manufacturer established in 1967. The company specializes in the research, development, production, and marketing of a wide range of pharmaceutical products, including generic Western medicines, Active Pharmaceutical Ingredients (APIs), and healthcare supplements. Its therapeutic portfolio covers diverse areas such as cardiovascular, metabolic, respiratory, anti-infective, and musculoskeletal systems, as well as dermatological and urogenital treatments. As a prominent generic drug manufacturer, the company operates with an integrated business model that spans from high-tech R&D to brand management and distribution. Adhering to international quality standards and ISO 9001 certification, it focuses on technological innovation and sustainable growth to serve diverse healthcare needs across domestic and international markets.

Recent filings

Filing Released Lang Actions
115年第1季海外子公司投資
Interim / Quarterly Report Classification · 85% confidence The document is a Taiwanese (公開資訊觀測站) quarterly submission for the 1st quarter of fiscal year 115, providing detailed financial data on overseas subsidiary investments (e.g., original investment, period-end balances, recognized income). It contains substantive financial tables typical of an Interim/Quarterly Report rather than a simple announcement or earnings highlight. Therefore, it fits the definition of an Interim/Quarterly Report (IR). Q1 2026
2026-05-14 Chinese
115年第1季大陸投資
Regulatory Filings Classification · 85% confidence The document is a disclosure form from Taiwan’s “公開資訊觀測站” detailing investment amounts and balances for Mainland China–based subsidiaries (年度115 季別01). It is a standalone compliance schedule showing numeric investment data rather than a complete interim or annual financial report, earnings release, or other predefined category. It lacks narrative analysis or broader financial statements, and serves as a regulatory filing under local investment rules. Therefore it is best classified as a general regulatory filing (RNS).
2026-05-14 Chinese
115年第1季財務報告書 — 202601_1720_AI1.pdf
Interim / Quarterly Report Classification · 90% confidence The document is a consolidated financial report for the first quarter of the fiscal years 115 and 114, complete with an auditor’s (PwC) review opinion, full interim financial statements (balance sheet, income statement, cash flows, equity changes), and extensive notes. It covers a period shorter than a full fiscal year and contains substantive financial data rather than mere highlights or a publication announcement. This matches the definition of an Interim/Quarterly Report (IR). Q1 115
2026-05-13 Chinese
115年第1季權益變動表
Interim / Quarterly Report Classification · 90% confidence The document is a consolidated statement of changes in equity (“合併權益變動表”) for the company’s first quarter (民國115年第1季) and provides detailed interim financial data (equity balances, movements, net income, OCI, etc.). It contains substantive financial statements for a period shorter than a full fiscal year and is not merely an announcement or link to another report. Therefore, it qualifies as an Interim/Quarterly Report. Q1 2026
2026-05-13 Chinese
115年第1季現金流量表
Regulatory Filings Classification · 8% confidence The provided text is merely an inaccessible page error message containing no substantive corporate or financial content. It does not match any specific filing category and thus defaults to the fallback category for miscellaneous regulatory filings.
2026-05-13 Chinese
115年第1季綜合損益表
Regulatory Filings Classification · 9% confidence The document contains only a webpage access error message and no substantive corporate filing content. It does not fit any specific filing category and serves as a generic web error notice. Classified as Regulatory Filings (RNS) as the fallback category.
2026-05-13 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.